Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital
Related Experiment Video
Updated: May 10, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
R J Drew1, J F Turton, R L R Hill
1Department of Microbiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Richard.drew@alderhey.nhs.uk
Insights
Carbapenem-resistant Enterobacteriaceae (CRE) are a growing threat in UK children's hospitals. Active surveillance is crucial for monitoring and controlling these infections, especially those with carbapenemases.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Paediatric Healthcare
Background:
- Carbapenem-resistant Enterobacteriaceae (CRE) pose a significant and increasing global infection risk.
- Limited data exist on the clinical impact and prevalence of CRE infections specifically within paediatric populations.
- Understanding CRE epidemiology in children is vital for effective infection control.
Purpose of the Study:
- To determine the prevalence of CRE in clinical and surveillance samples from a UK tertiary children's hospital.
- To identify the resistance mechanisms employed by CRE isolates in this paediatric setting.
- To characterize carbapenemase-producing strains using molecular typing.
Main Methods:
- Retrospective analysis of clinical and surveillance specimens collected between September 2011 and August 2012.
- Phenotypic and molecular methods were used to ascertain carbapenem resistance mechanisms.
- Variable number tandem repeat (VNTR) profiling was employed for typing carbapenemase-producing isolates.
Main Results:
- CRE were identified in 24 patients over a 12-month period.
- The prevalence of CRE detected via rectal surveillance was 4.5% (19/421 patients).
- Seven isolates harboured carbapenemases (three blaKPC, four blaNDM); 17 exhibited resistance via AmpC/ESBLs and impermeability.
Conclusions:
- CRE, particularly carbapenemase-producers, represent an emerging infectious challenge in UK paediatric hospitals.
- The findings underscore the need for robust active surveillance programs to manage and mitigate CRE spread in children.
- Early detection and characterization of CRE are essential for guiding clinical management and public health interventions.
Background:
Carbapenem-resistant Enterobacteriaceae are an emerging global infection threat. However, there are few data describing their clinical importance in children.
Aim:
This retrospective study reviewed the prevalence and resistance mechanisms of carbapenem-resistant Enterobacteriaceae grown from clinical and surveillance samples in a large tertiary referral children's hospital in the UK.
Methods:
Carbapenem-resistant Enterobacteriaceae were sought in specimens submitted for diagnostic and surveillance purposes at Alder Hey Children's NHS Foundation Trust, Liverpool, between September 2011 and August 2012. Mechanisms of resistance were identified using phenotypic and/or molecular methods. Variable number tandem repeat profiling was used to type carbapenemase-producing strains.
Findings:
During the 12-month study period, carbapenem-resistant Enterobacteriaceae were recovered from 24 patients. Five isolates were from clinical diagnostic specimens whereas 19 of 421 patients had positive rectal surveillance swabs (4.5%). Of the 24 isolates, seven (all Klebsiella spp.) harboured carbapenemases: three had blaKPC and four blaNDM, whereas 17 had resistance due to combinations of AmpC or extended-spectrum β-lactamase activity plus impermeability.
Conclusion:
Carbapenem-resistant Enterobacteriaceae and, in particular, those with carbapenemases, are an emerging infection problem in a major paediatric hospital in the UK. Active surveillance is required to monitor and control their spread.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pneumonia I: Introduction
